Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Tissue rigidity promotes tumor progression

Tissue rigidity promotes tumor progression

September 20, 2005

Most investigations into cancer have focused on chemical signals, but a new research study provides rare insight into how mechanical force can regulate cellular behavior.

The study uncovers a link between tissue tension and tumor formation, suggesting that the stiffness of a tissue can influence molecular signals that promote the malignant behavior of tumor cells. The findings, published in the September issue of Cancer Cell, provide exciting new insight into the mechanisms that link the tissue microenvironment with tumorigenesis, and may identify new targets for tumor therapies.




Tumors are more rigid than normal tissues, and palpation of compliant tissues to look for a rigid tissue mass has been used as a method of cancer detection for some time. However, the relationship between tissue stiffness and the behavior of tumor cells is not well understood. Dr. Valerie M. Weaver, from the University of Pennsylvania in Philadelphia, and colleagues examined cancer cells developing within a three-dimensional gel system in which rigidity could be carefully controlled to look at how tissue stiffening might drive malignant behavior of cancer cells.

Research focused on a class of molecules called integrins that function as transducers of physical cues and are known to regulate growth factor signaling. The researchers found that even a slight increase in the stiffness of the surrounding matrix perturbed tissue architecture and enhanced growth by inducing Rho-generated cytoskeletal tension to promote assembly of integrin-associated attachments called focal adhesions and increase growth factor-dependent ERK activation. Further, a decrease in Rho or ERK activity in cancerous cells was associated with a subsequent decline of focal adhesions and a reversion of aberrant morphological structures.

The results of the research study provide a link between exogenous force, Rho-associated cytoskeletal tension, focal adhesions, and growth factor activation of ERK, and offer a fresh perspective for understanding the molecular basis of tissue differentiation and tumor formation. According to Dr. Weaver, "ERK and Rho appear to be part of an integrated mechanoregulatory circuit that functions to link physical cues through integrins to molecular pathways that control cell growth. A chronic increase in cytoskeletal tension could enhance growth and perturb tissue organization, thereby promoting malignant transformation of a tissue."

Cell Press



Related Tumor Progression Current Events and Tumor Progression News Articles Tumor Progression Current Events and Tumor Progression News RSS Tumor Progression Current Events and Tumor Progression News RSS
Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.

Mayo Clinic Researchers Find That Protein Believed to Protect Against Cancer Has a Mr. Hyde Side
In a biological rendition of fiction's Strange Case of Dr. Jekyll and Mr. Hyde, researchers from the Mayo Clinic campus in Florida and Harvard Medical School have found that a protein thought to protect against cancer development can actually spur the spread of tumors.

New molecular markers for tumor aggressiveness in biliary tract cancer
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies.

2 software tools that improve identification of cancer biomarkers earn certification
The explosive growth of genomic and proteomic data has ushered in a new era of molecular medicine in which cancer detection, diagnosis and treatment are tailored to each individual's molecular profile.

Einstein researchers identify potential target for metastatic cancer
The deadliest part of the cancer process, metastasis, appears to rely on help from macrophages, potent immune system cells that usually defend vigorously against disease, researchers at Albert Einstein College of Medicine of Yeshiva University report.

Novel epigenetic markers of melanoma may herald new treatments for patients
Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually. While the rate of incidences continues to rise, survival rate has not improved and the race is on to find the genetic and cellular changes driving melanoma and to devise new means of detection and treatment.

Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease.

Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior.

Research uncovers clues to virus-cancer link
In a series of recently-published articles, a research team from the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has uncovered clues to the development of cancers in AIDS patients.

Protein linked to change in tissue that surround and support breast tumors
A protein known to be overly active in breast cancer can exist in a form that seems to change the structural composition of mammary tissue, potentially making it more conducive to tumor progression, say researchers from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC).
More Tumor Progression Current Events and Tumor Progression News Articles
Tumor Progression and Therapeutic Resistance (Annals of the New York Academy of Sciences)

Tumor Progression and Therapeutic Resistance (Annals of the New York Academy of Sciences)
by Wafik S. El-Deiry (Editor)

The entire breadth of translational cancer research is addressed in this volume, which brings together members of academia and industry in the expectation of accelerating interactions and progress in the field.

A variety of key topics are presented, beginning with discovery of molecular targets and pathways (oncogene, cell survival, tumor suppression, cell death), host-neoplasm interactions (cell adhesion, matrix proteases), early detection, monitoring progression, understanding tumor progression and metastasis, immune surveillance, in vivo molecular imaging, animal models, drug discovery including chemistry, high-throughput assays, mechanism determination, target validation, therapeutic window and some progress in clinical trials for more advanced agents and targets.
...

Regulation of Gene Expression in the Tumor Environment: Regulation of melanoma progression by the microenvironment: the roles of PAR-1 and PAFR (The Tumor Microenvironment)

Regulation of Gene Expression in the Tumor Environment: Regulation of melanoma progression by the microenvironment: the roles of PAR-1 and PAFR (The Tumor Microenvironment)
by Menashe Bar-Eli (Author), Menashe Bar-Eli (Editor)

It is now becoming very clear that the development and progression of tumor towards the malignant (metastatic) phenotype depends tightly on the interaction between the tumor cells and the tumor microenvironment. Tumor cells respond to stimuli generated within the tumor microenvironment for their growth advantage while the tumor cell themselves reshape and remodel the architecture and function of their extracellular matrices. The term tumor microenvironment is a wide umbrella consisting of stromal cells such as fibroblasts and endothelial cells and infiltration immune cells including T and B cells, macrophages, and other inflammatory cells (PMNs). These different components of the tumor microenvironment could have stimulatory and inhibitory effects on tumor progression by regulating the...

  Targeted therapy thwarts tumor progression.(gastrointestinal stromal tumors treated with sunitinib)(Drug overview): An article from: Internal Medicine News
by Betsy Bates (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on April 1, 2006. The length of the article is 564 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Targeted therapy thwarts tumor progression.(gastrointestinal stromal tumors treated with sunitinib)(Drug overview)
Author: Betsy Bates
Publication: Internal Medicine News (Magazine/Journal)
Date: April 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 7 Page: 55(1)

Article Type: Drug overview

Distributed by Thomson...

  Influence of the Host on Tumor Development (Cancer Growth and Progression)
by Ronald B. Herberman (Editor)

X

  Targeted therapy thwarts tumor progression: sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.(Digestive ... An article from: Family Practice News
by Betsy Bates (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on March 15, 2006. The length of the article is 564 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Targeted therapy thwarts tumor progression: sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.(Digestive Disorders)(Drug overview)
Author: Betsy Bates
Publication: Family Practice News (Magazine/Journal)
Date: March 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 6 Page: 62(1)

Article Type: Drug...

  Egf Receptor in Tumor Growth and Progression (Ernst Schering Research Foundation Workshop, 19)
by R. B. Lichtner (Editor), R. N. Harkins (Editor)

The tyrosine kinases are frequently implicated in experimental as well as in human cancer. The best-studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system.

  Regulation of Hyaluronan Biosynthesis: Expression in Vitro & Importance for Tumor Progression (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1148)
by Annica Jacobson (Author)



  Comparative Aspects of Tumor Development (Cancer Growth and Progression)
by H.E. Kaiser (Editor)



  Headache change could signal brain tumor: neurologic 'red flag'.(Clinical Rounds): An article from: Family Practice News
by Nancy A. Melville (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2004. The length of the article is 566 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Headache change could signal brain tumor: neurologic 'red flag'.(Clinical Rounds)
Author: Nancy A. Melville
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 2 Page: 24(1)

Distributed by Thomson...

  BCC depth influenced by histologic subtype, tumor width, and male sex. (Location has no Impact).(basal cell carcinoma): An article from: Skin & Allergy News
by International Medical News Group (Publisher)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on January 1, 2002. The length of the article is 6610 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: BCC depth influenced by histologic subtype, tumor width, and male sex. (Location has no Impact).(basal cell carcinoma)
Publication: Skin & Allergy News (Magazine/Journal)
Date: January 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 1 Page: 24(1)

Distributed by Thomson...

© 2009 BrightSurf.com